Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach

Journal of Medicinal Chemistry

Volumn 41, Issue 13, 1998, Pages 2261-2267

  Sadler, Beth R ^a,b   Cho, Sung Jin ^b   Ishaq, Khalid S ^b   Chae, Kun ^a   Korach, Kenneth S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR;

ARTICLE; DRUG CONFORMATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR AFFINITY; STEREOISOMERISM;

ANIMALS; DIETHYLSTILBESTROL; ESTROGENS, NON-STEROIDAL; INDENES; LIGANDS; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; RECEPTORS, ESTROGEN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 15644363344     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9705521     Document Type: Article

References (33)

1. Manglesdorf, D. J.; Thummel, C.; Beato, M.; Herrlich, P.; Shutz, G.; Umesono, K.; Blumberg, B.; Kastner, P.; Mark, M.; Charmbon, P.; Evans, R. M. The nuclear receptor superfamily: the second decade. Cell 1995, 83, 835-839.
2. Beekman, J. M.; Allan, G. F.; Tsai, S. Y.; Tsai, M.-J.; O'Malley, B. W. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol. Endocrinol. 1993, 267, 19513-19520.
3. Katzenellenbogen, J. A.; O'Malley, B. W.; Katzenellenbogen, B. S. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell-and promoter-specific action of these hormones. Mol. Endocrinol. 1996, 10, 119-131.
4. Korach, K. S. Biochemical and estrogenic activity of some diethylstilbestrol metabolites and analogues in the mouse uterus. In Hormones and Cancer; Leavitt, W., Ed.; Plenum: New York, 1982; pp 39-62.
5. Korach, K. S.; Chae, K.; Levy, L. A.; Duax, W. L.; Sarvar, P. J. Diethylstilbestrol metabolites and analogues: stereochemical probes for the estrogen receptor binding site. J. Biol. Chem. 1989, 264, 5642-5647.
6. Chae, K.; Gibson, M.; Korach, K. S. Estrogen receptor stereo-chemistry: ligand binding orientation and influence on biological activity. Mol. Pharmacol. 1991, 40, 806-811.
7. Duax, W. L.; Swenson, D. C.; Strong, P. D.; Korach, K. S.; McLachlan, J.; Metzler, M. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity. Mol. Pharmacol. 1984, 26, 520-525.
8. Anstead, G. M.; Wilson, S. R.; Katzenellenbogen, J. A. 2-Arylindenes and 2-arylindenones: molecular structures and considerations in the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor. J. Med. Chem. 1989, 32, 2163-2171.
9. Gramer, R. D., III; Patterson, D. E.; Bunce, J. D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
10. Gantchev, T. G.; Ali, H.; van Lier, J. E. Quantitative structure-activity relationships/comparative molecular field analysis (QSAR/ CoMFA) for receptor-binding properties of halogenated estradiol derivatives. J. Med. Chem. 1994, 37, 4164-4176.
11. Waller, C.; Minor, D. L.; McKinney, J. D. Using three-dimensional quantitative structure-activity relationships to examine estrogen receptor binding affinities of polychlorinated biphenyls. Environ. Health Perspect. 1905, 103, 702-707.
12. Waller, C.; Oprea, T. I.; Chae, K.; Park, H.-K.; Korach, K. S.; Laws, S. C.; Wiese, T. E.; Kelce, W. R.; Gray, L. E., Jr. Ligand-based identification of environmental estrogens. Chem. Res. Toxicol. 1996, 9, 1240-1248.
13. 2 guided region selection for comparative molecular field analysis (CoMFA): a simple method to achieve consistent results. J. Med. Chem. 1995, 38, 1060-1066.
14. Tripos inc., 1699 S. Hanley Rd., Suite 303, St. Louis, MO 63144.
15. Clark, M.; Cramer, R. D., III; Van Opdenbosch, N. Validation of the general purpose Tripos 5.2 force field. J. Comput. Chem. 1989, 10, 982-1012.
16. Korach, K. S. Estrogen action in the mouse uterus: characterization of cytosol and nuclear receptor systems. Endocrinology 1979, 104, 1324-1332.
17. Duax, W. L. The structure of the crystalline complex estradiol urea (1:1). Acta Crystallogr. 1972, B28, 1864-1871.
18. Busetta, P. B.; Hospital, C. C. Etude cristallographique de differentes formes solvatees du diethylstilboestrol. (Crystal-lographic study of different solvated forms of diethylstilbestrol.) Acta Crystallogr. 1973, B29, 2456-2462.
19. Doyle, T. D.; Stewart, J. M.; Filipescu, N.; Benson, W. R. Configuration of dienestrol. J. Pharm. Sci. 1975, 64, 1525-1528.
20. Chernyaev, G. A.; Barkova, T. I; Egorova, V.; Sorokina, I. B.; Anachenko, S. N.; Matarodze, G. D.; Sokolova, N. A.; Rozen, V. B. A series of optical structural and isomeric analogues of estradiol: a comparative study of the biological activity and affinity to cytosol receptor of rabbit uterus. J. Steroid Biochem. 1975, 6, 1483-1488.
21. Duax, W. L.; Weeks, C. M. Molecular basis of estrogenicity: X-ray crystallographic studies. In Estrogens in the Environment; McLachlan, J., Ed.; Elsevier/North-Holland: New York, 1980; pp 111-131.
22. 2-GRS approach. J. Med. Chem. 1996, 39, 1383-1395.
23. Cho, S. J.; Garsia, M. L. S.; Bier, J.; Tropsha, A. Structure-based alignment and comparative molecular field analysis of acetyl-cholinesterase inhibitors. J. Med. Chem. 1996, 39, 5064-5071.
24. Korach, K. S.; Chae, K.; Gibson, M.; Curtis, S. Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness. Steroids 1991, 56, 263-270.
25. Napolitano, E.; Fiaschi, R.; Carlson, K. E.; Katzenellenbogen, J. A. 11-Beta substituted estradiol derivatives - potential high-affinity carbon-11-labeled probes for the estrogen receptor: a structure-activity-relationship. J. Med. Chem. 1995, 38, 429-434.
26. Leclercq, G.; Heuson, J. C. Drug interaction with estrogen receptors for the control of breast neoplasia (review.). Anticancer Res. 1981, 1, 217-228.
27. Poupaert, J. H.; Lambert, D. M.; Vamecq, J.; Abul-Hajj, Y. J. Molecular modeling studies on 11β-aminoethoxyphenyl and 7α-aminoethoxyphenyl estradiols. evidence suggesting a common hydrophobic pocket in estrogen receptor. Bioorg. Med. Chem. Lett. 1995, 5, 839-842.
28. Duax, W. L.; Griffin, J. F.; Rohrer, D. C.; Swenson, D. C.; Weeks, C. M. Molecular details of receptor binding and hormonal action of steroids derived from X-ray crystallographic investigations. J. Steroid Biochem. 1981, 15, 41-47.
29. Poirier, D.; Merand, Y.; Labrie, C.; Labrie, F. D-ring alkylamide derivatives of estradiol: effect on ER-binding affinity and antiestrogenic activity. Bioorg. Med. Chem. Lett. 1996, 6, 2537-2542.
30. Grese, T. A.; Cho, S.; Finely, D. R.; Godfrey, A. G.; Jones, C. D.; Lugar, C. W., III; Martin, M. J.; Matsumoto, K.; Pennington, L. D.; Winter, M. A.; Adrian, M. D.; Cole, H. W.; Magee, D. E.; Phillips, D. L.; Rowley, E. R.; Short, L. L.; Glasebrook, A. L.; Bryant, H. U. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylben-zothiophene core of raloxifene. J. Med. Chem. 1997, 40, 146-167.
31. Duax, W. L.; Griffen, J. F.; Weeks, C. M.; Wawrzak, Z. The mechanism of action of steroid antagonists: insights from crystallographic studies. J. Steroid Biochem. 1988, 31, 481-492.
32. Korach, K. S.; Sarver, P.; Chae, K.; McLachlan, J. A.; McKinney, J. Estrogen receptor binding activity of polychlorinated hydroxy-biphenyls: conformationally restricted structural probes. Mol. Pharmacol. 1987, 33, 120-126.
33. Korach, K. S.; Metzler, M.; McLachlan, J. A. Estrogenic activity in vivo and in vitro of some diethylstilbestrol metabolites and analogues. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 468-471.